###begin article-title 0
Structural and Functional Similarity between the Bacterial Type III Secretion System Needle Protein PrgI and the Eukaryotic Apoptosis Bcl-2 Proteins
###end article-title 0
###begin p 1
Conceived and designed the experiments: RP. Performed the experiments: MDS. Analyzed the data: MDS RP. Wrote the paper: MDS RP.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Functional similarity is challenging to identify when global sequence and structure similarity is low. Active-sites or functionally relevant regions are evolutionarily more stable relative to the remainder of a protein structure and provide an alternative means to identify potential functional similarity between proteins. We recently developed the FAST-NMR methodology to discover biochemical functions or functional hypotheses of proteins of unknown function by experimentally identifying ligand binding sites. FAST-NMR utilizes our CPASS software and database to assign a function based on a similarity in the structure and sequence of ligand binding sites between proteins of known and unknown function.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 22 44 22 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Salmonella typhimurium</italic>
###xml 22 44 <span type="species:ncbi:90371">Salmonella typhimurium</span>
The PrgI protein from Salmonella typhimurium forms the needle complex in the type III secretion system (T3SS). A FAST-NMR screen identified a similarity between the ligand binding sites of PrgI and the Bcl-2 apoptosis protein Bcl-xL. These ligand binding sites correlate with known protein-protein binding interfaces required for oligomerization. Both proteins form membrane pores through this oligomerization to release effector proteins to stimulate cell death. Structural analysis indicates an overlap between the PrgI structure and the pore forming motif of Bcl-xL. A sequence alignment indicates conservation between the PrgI and Bcl-xL ligand binding sites and pore formation regions. This active-site similarity was then used to verify that chelerythrine, a known Bcl-xL inhibitor, also binds PrgI.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
A structural and functional relationship between the bacterial T3SS and eukaryotic apoptosis was identified using our FAST-NMR ligand affinity screen in combination with a bioinformatic analysis based on our CPASS program. A similarity between PrgI and Bcl-xL is not readily apparent using traditional global sequence and structure analysis, but was only identified because of conservation in ligand binding sites. These results demonstrate the unique opportunity that ligand-binding sites provide for the identification of functional relationships when global sequence and structural information is limited.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 104 107 104 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Gerlt1">[1]</xref>
###xml 109 112 109 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Mirny1">[2]</xref>
###xml 309 312 309 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Park1">[3]</xref>
###xml 492 495 492 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Campbell1">[4]</xref>
###xml 497 500 497 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Powers1">[5]</xref>
###xml 869 872 869 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Powers1">[5]</xref>
###xml 873 876 873 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Powers2">[7]</xref>
###xml 1132 1135 1132 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Powers3">[8]</xref>
Functional regions of a protein are evolutionarily more stable relative to the remainder of the protein [1], [2]. The evolutionary correlation between ligand binding sites, ligand structure and protein function has also been demonstrated by a network of ligand-binding-site similarity described by Park & Kim [3]. A variety of computational methods have attempted to exploit the evolutionary stability of functional regions by identifying ligand binding sites as a method to predict function [4], [5]. Unfortunately, the combined requirements of predicting the ligand, the binding site, and a similarity to an annotated protein lead to a high level of ambiguity. Recently, we developed the Functional Annotation Screening Technology by Nuclear Magnetic Resonance (FAST-NMR) assay to experimentally identify ligand binding sites to annotate proteins of unknown function [5]-[7]. FAST-NMR utilizes the Comparison of Protein Active Site Structures (CPASS) software and database to identify similar sequence and structure characteristics between experimentally identified ligand binding sites for proteins of known and unknown function [8]. Applying the FAST-NMR method on previously annotated systems also enables experimental ligand binding site data to identify functional relationships that otherwise would not be recognized based solely on global sequence and structure similarity.
###end p 9
###begin p 10
###xml 172 175 172 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Cornelis1">[9]</xref>
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Macnab1">[11]</xref>
###xml 185 207 185 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Salmonella typhimurium</italic>
###xml 332 346 332 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. typhimurium</italic>
###xml 365 369 365 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Galan1">[12]</xref>
###xml 483 487 483 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Grassme1">[13]</xref>
###xml 544 548 544 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Yan1">[14]</xref>
###xml 711 715 699 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Wang1">[15]</xref>
###xml 894 898 882 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Wang1">[15]</xref>
###xml 899 903 887 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Torruellas1">[17]</xref>
###xml 1146 1160 1134 1148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. typhimurium</italic>
###xml 185 207 <span type="species:ncbi:90371">Salmonella typhimurium</span>
###xml 332 346 <span type="species:ncbi:90371">S. typhimurium</span>
###xml 1146 1160 <span type="species:ncbi:90371">S. typhimurium</span>
The type three secretion system (T3SS) is composed of 20-25 different proteins, which are assembled in a highly choreographed mechanism similar to the assembly of flagella [9]-[11]. In Salmonella typhimurium, the needle complex is responsible for puncturing a host's cell membrane to allow effector proteins (SipB, SipC, SipD) from S. typhimurium to enter the host [12]. Many of these effectors can activate bacterial induced apoptosis of a hosts' cell by interacting with capsase-1 [13] in a mechanism similar to apoptosis in eukaryotic cells [14]. The needle complex is a large homomultimer composed of approximately120 repeated copies of the monomeric protein PrgI, a small helical protein of 83 amino acids [15]. The monomeric form of PrgI is a helix-turn-helix motif with two symmetrically charged surfaces and a conserved loop region, PxxP domain, which are important for needle assembly [15]-[17]. The charged surfaces of PrgI responsible for needle assembly also provide a potential binding site for small molecule ligands. This makes PrgI an attractive drug target to disrupt the formation of the needle complex and prevent infection by S. typhimurium. However, to date there have been no reported ligands that bind to either region of this protein-protein interaction site.
###end p 10
###begin p 11
###xml 37 51 37 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. typhimurium</italic>
###xml 256 260 256 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Dietmann1">[18]</xref>
###xml 274 278 274 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Poirot1">[19]</xref>
###xml 521 525 521 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Chan1">[20]</xref>
###xml 37 51 <span type="species:ncbi:90371">S. typhimurium</span>
###xml 267 273 <span type="species:ncbi:13443">Coffee</span>
The PrgI needle complex protein from S. typhimurium T3SS was screened in our FAST-NMR assay, which resulted in the identification of a functional similarity between the ligand binding sites of PrgI and the anti-apoptosis protein Bcl-xL. Additionally, Dali [18] and T-Coffee [19] analysis found regions of structure and sequence similarity between the two proteins consistent with the FAST-NMR results. The predicted active-site similarity between PrgI and Bcl-xL was also used to experimentally verify that chelerythrine [20], a ligand known to inhibit Bcl-xL and induce apoptosis, also binds PrgI. These results provide experimental evidence that suggest a functional relationship between the bacterial type III secretion systems and apoptosis. This is consistent with a general conservation in function between PrgI and the Bcl-2 family of proteins that includes Bcl-xL; both form membrane pores through oligomerization using a conserved helix-turn-helix motif to release effectors to stimulate cell death.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
Results from the FAST-NMR screen
###end title 13
###begin p 14
###xml 39 53 39 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. typhimurium</italic>
###xml 227 231 227 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Muller1">[21]</xref>
###xml 449 453 449 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Wang1">[15]</xref>
###xml 516 519 516 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Mercier1">[6]</xref>
###xml 569 573 569 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Mercier2">[22]</xref>
###xml 616 620 616 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Mercier3">[23]</xref>
###xml 664 667 664 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Powers3">[8]</xref>
###xml 714 718 714 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Stark1">[24]</xref>
###xml 39 53 <span type="species:ncbi:90371">S. typhimurium</span>
The needle complex protein, PrgI, from S. typhimurium is an attractive antibacterial target because the protein is exposed to the cell surface and blocking this target could prevent injection of virulence factors into the host [21]. The interaction of PrgI with the host membrane stimulates the delivery of effectors from the bacteria into the host cytosol to induce cell death. Recently an NMR structure was determined for a monomeric form of PrgI [15], which enabled the screening of PrgI using the FAST-NMR assay [6]. FAST-NMR combines NMR ligand affinity screening [22] using a fragment-based functional library [23] with structural biology and bioinformatics [8] to rapidly determine protein-ligand complexes [24] and infer functional relationship between proteins based on similarities in functional epitopes. Also, the resulting protein-ligand co-structure provides a valuable starting point for structure-based drug design.
###end p 14
###begin p 15
###xml 48 52 48 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Mercier2">[22]</xref>
###xml 100 108 100 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007442-g001">Figure 1</xref>
###xml 182 183 182 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 408 409 408 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 506 507 502 503 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 573 582 569 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007442-g001">Figure 1A</xref>
###xml 611 613 607 609 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 615 616 611 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 740 749 736 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007442-g001">Figure 1B</xref>
###xml 925 927 921 923 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 929 930 925 926 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 1043 1044 1039 1040 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 1042 1044 1038 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K<sub>d</sub></italic>
###xml 1081 1082 1073 1074 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 1107 1111 1099 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Shortridge1">[25]</xref>
###xml 1308 1312 1300 1304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Kubori1">[26]</xref>
FAST-NMR applies a tiered approach to screening [22] to minimize resources and increase throughput (Figure 1). First, PrgI was screened with the functional chemical library using 1D 1H NMR line-broadening experiments. Five compounds (L-carnitine inner salt, didecyldimethylammonium bromide, 1-methylimidazole, methiothepin mesylate salt, sucrose) were found to bind PrgI by showing a significant decrease in 1H peak intensity upon addition of 25 microM of PrgI. This was determined by comparing normalized 1H ligand peak intensities between the free and bound NMR spectra (Figure 1A). However, the secondary 2D 15N-1H HSQC experiments identified the lipid derivative didecyldimethylammonium bromide (DDAB) as the only specific PrgI binder (Figure 1B) based on the observation of a significant number of chemical shift changes in the spectrum. The remaining four compounds elicited no change in chemical shifts in the PrgI 2D 15N-1H HSQC spectrum, which suggest the compounds bound non-specifically to PrgI. PrgI was found to bind DDAB with a Kd of 553 microM as calculated by a 1D 1H line broadening method [25]. Finding a lipid derivative that specifically binds to PrgI is consistent with the protein's function; sensing new host cells and signaling secretion through an interaction with the host membrane [26].
###end p 15
###begin title 16
Identification of PrgI Binding Ligands.
###end title 16
###begin p 17
###xml 37 40 37 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">top</italic>
###xml 56 62 56 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bottom</italic>
###xml 162 163 162 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 271 273 271 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 275 276 275 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 447 451 447 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Humphrey1">[78]</xref>
###xml 619 623 619 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Morris1">[27]</xref>
###xml 655 659 655 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Stark1">[24]</xref>
(A) DDAB NMR spectra in the absence (top) and presence (bottom) of PrgI illustrating changes in NMR intensities (boxed) upon binding PrgI. Both free and bound 1D 1H NMR spectra were normalized to a constant DMSO signal intensity. (B) Expanded view of the superimposed 2D 15N-1H HSQC spectra of the free and DDAB bound PrgI NMR samples. Residues that incur a chemical shift perturbation are boxed. (C) Expanded view of PrgI surface rendered in VMD [78] where residues that incur a chemical shift change are colored blue and DDAB is colored yellow. Co-structure based on NMR determined ligand binding site using AutoDock [27] and our AutoDockFilter program [24].
###end p 17
###begin p 18
###xml 46 48 46 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 50 51 50 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 297 306 297 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007442-g001">Figure 1C</xref>
###xml 669 673 669 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Kimbrough1">[10]</xref>
###xml 898 902 898 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Wang1">[15]</xref>
###xml 903 907 903 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Torruellas1">[17]</xref>
###xml 1034 1038 1034 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Wang1">[15]</xref>
###xml 1039 1043 1039 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Torruellas1">[17]</xref>
Chemical shift perturbations (CSPs) in the 2D 15N-1H HSQC experiments between free PrgI and the complex identified the PrgI residues that bind DDAB. Mapping these CSPs onto the PrgI surface identified the DDAB binding site as corresponding to residues at the bifurcation point of the two helices (Figure 1C). Specifically, residues S6, L9, S13, K15, and D17 of helix 1 and N59, V65, K66, V67, F68, K69, D70, D72, A73 and L76 of helix 2 showed significant CSPs in the presence of DDAB as calculated by equation 1. This ligand binding site has been shown to be important for the formation of the T3SS needle complex in which PrgI forms a repeating coiled-coils structure [10]. According to recent alanine scanning and structural studies, the surface residues in the region between the bifurcation point of the two helices and the conserved loop region, PxxP domain, are important for needle assembly [15]-[17]. These residues bind to the backside of the bifurcation point of the two helices in a stacked N-terminus to C-terminus manner [15]-[17].
###end p 18
###begin p 19
###xml 195 199 195 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Stark1">[24]</xref>
###xml 214 218 214 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Morris1">[27]</xref>
###xml 429 433 429 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Stark1">[24]</xref>
###xml 576 585 576 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007442-g001">Figure 1C</xref>
The PrgI residues exhibiting significant CSPs upon binding DDAB were used to guide and filter a molecular docking simulation based on our method to rapidly determine protein-ligand co-structures [24]. AutoDock 4.0 [27] was used to calculate 100 docked structures within a 3D grid defined by the CSPs. Our AutoDock Filter program (ADF) selected the best conformer based on consistency with the magnitude of chemical shift changes [24]. The ligand is expected to be closest to the protein residues that incurred the largest CSPs. The best PrgI-DDAB docked structure is shown in Figure 1C, where DDAB adopts an extended conformation that straddles both helices of PrgI.
###end p 19
###begin title 20
Analysis of CPASS and Structure Similarity Results
###end title 20
###begin p 21
###xml 254 258 254 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Oltersdorf1">[28]</xref>
###xml 370 379 370 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007442-g002">Figure 2A</xref>
###xml 100 105 <span type="species:ncbi:9606">human</span>
Comparison of Protein Active Site Structures (CPASS) analysis of the PrgI-DDAB complex identified a human Bcl-2 protein family member (the anti-apoptosis regulating protein Bcl-xL (PDB-ID:1YSN) complexed to an acyl-sulfonamide-based inhibitor (ABT-737)) [28] as the top hit based on a ligand binding-site CPASS similarity score of 37.7%. The CPASS alignment is shown in Figure 2A and is based on maximizing the spatial orientation of similar residue types between the two ligand-binding sites. All other proteins with a CPASS similarity >30% were also evaluated, but Bcl-xL was the only protein that gave a reliable CPASS score and showed some level of structure or sequence similarity to PrgI. It is important to note that the CPASS identified similarity between PrgI and Bcl-xL was fundamentally dependent on the existence of a Bcl-xL-ligand complex in the PDB. Ligand complexes for other members of the Bcl-2 protein family (Bax, Bid) currently do not exist.
###end p 21
###begin title 22
Active Site Similarity between PrgI and Bcl-xL.
###end title 22
###begin p 23
###xml 27 41 27 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. typhimurium</italic>
###xml 410 424 410 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. typhimurium</italic>
###xml 462 466 462 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Holm1">[29]</xref>
###xml 548 562 548 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. typhimurium</italic>
###xml 569 584 569 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 595 606 595 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. flexneri</italic>
###xml 767 771 767 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Notredame1">[35]</xref>
###xml 27 41 <span type="species:ncbi:90371">S. typhimurium</span>
###xml 101 106 <span type="species:ncbi:9606">human</span>
###xml 379 384 <span type="species:ncbi:9606">human</span>
###xml 410 424 <span type="species:ncbi:90371">S. typhimurium</span>
###xml 548 562 <span type="species:ncbi:90371">S. typhimurium</span>
###xml 569 584 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 595 606 <span type="species:ncbi:623">S. flexneri</span>
###xml 621 626 <span type="species:ncbi:9606">human</span>
(A) CPASS alignment of the S. typhimurium PrgI active-site complexed to DDAB with the active-site of human Bcl-2 protein (Bcl-xL) complexed with acyl-sulfonamide-based inhibitor. The residues aligned by CPASS are labeled and colored blue in the structures. The active site sequence alignment is also shown below the structures. The ligands are colored yellow. (B) Overlay of the human Bcl-2 protein (red) with S. typhimurium PrgI (turquoise) based on a DaliLite [29] alignment. (C) Multiple-sequence alignment of the three known T3SS structures of S. typhimurium PrgI, B. pseudomallei BsaL, and S. flexneri MxiH with the human Bcl-2 protein (Bcl-xL). The reliability of the each amino acid alignment is color-coded from blue (poor) to red (good) using the CORE index [35]. The consensus alignment received a score of 69, where a perfect alignment receives a score of 100.
###end p 23
###begin p 24
###xml 560 564 560 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Oltersdorf1">[28]</xref>
While DDAB and ABT-737 are distinctly different ligands, the compounds share strong similarities in their mode of protein interactions. ABT-737 binds Bcl-xL edge-on in an elongated conformation where a minimal number of atoms contact the hydrophobic binding cleft of Bcl-xL. In this manner, DDAB mimics this edge contact interaction of ABT-737 with the similar hydrophobic binding cleft in PrgI. Also, ABT-737 binds in a protein-protein binding interface similar to DDAB, where inhibiting protein interactions is the drug's mechanism of action in cancer cells [28]. Thus, the PrgI and Bcl-xL ligand binding-sites are functionally similar.
###end p 24
###begin p 25
###xml 46 50 46 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Holm1">[29]</xref>
###xml 401 410 393 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007442-g002">Figure 2B</xref>
A pairwise structure alignment using DaliLite [29] yielded a non-significant Z-score of 1.4 and only 6% sequence identity between PrgI (PDB ID:2JOW) and Bcl-xL (PDB ID:1YSN). Nevertheless, the helix-turn-helix structure of PrgI (residues S13-V65) overlaps the buried helix-turn-helix motif (N136-I182) in Bcl-xL that corresponds to helices alpha5 (residues W137-D156) and alpha6 (residues L162-D176) (Figure 2B). A focused pairwise comparison between the full PrgI protein and the alpha5 and alpha6 helices of Bcl-xL gave a low but significant Z-score of 3.3 with a root-mean-square-difference (rmsd) of 3.1 A. The sequence identity also increases from 6% to 9% between the full and focused pairwise alignments, respectively.
###end p 25
###begin p 26
###xml 472 480 472 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007442-g002">Figure 2</xref>
###xml 729 733 729 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Holm1">[29]</xref>
###xml 735 739 735 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Altschul1">[30]</xref>
While there is an overlap between the DaliLite alignment of PrgI with Bcl-xL and the protein ligand binding sites identified by CPASS, these sites are not identical. This arises because the CPASS similarity is not confined by the primary sequence of the two proteins, but simply captures the spatial orientation of conserved residues around a ligand binding site. This is illustrated by the non-sequential sequence alignment of the PrgI and Bcl-xL ligand binding sites in Figure 2. The exclusion of the sequence connectivity as a constraint to determine an alignment illustrates the advantage of CPASS in identifying a functional relationship and the limitation of global sequence and structure alignments such as Dali and BLAST [29], [30].
###end p 26
###begin title 27
Sequence Similarity Results
###end title 27
###begin p 28
###xml 8 12 8 12 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Altschul1">[30]</xref>
###xml 314 318 314 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Larkin1">[31]</xref>
###xml 471 475 471 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Rost1">[32]</xref>
###xml 614 619 <span type="species:ncbi:9606">human</span>
A BLAST [30] homology search using the PrgI and Bcl-xL sequences did not yield any significant information relating PrgI to Bcl-xL. The Bcl-xL sequence only identified homology to other Bcl-2 proteins. Similarly, the PrgI sequence was only aligned to other T3SS needle proteins. This is consistent with a ClustlW2 [31] sequence alignment between PrgI and Bcl-xL that resulted in a low 14.3% sequence similarity, which falls below the twilight zone of sequence similarity [32]. Also, focused BLAST searches did not provide any new information. Searching microbial genomes using the Bcl-2 sequences or searching the human genome with T3SS sequences did not identify any sequence alignments with significant E-values. Thus, global sequence alignments did not readily result in identifying any relationship between T3SS and apoptosis proteins. This highlights the power of active site similarity searches to identify potentially new functional similarities in proteins.
###end p 28
###begin p 29
###xml 34 38 34 38 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Bystroff1">[33]</xref>
###xml 319 323 319 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Poirot1">[19]</xref>
###xml 369 378 369 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007442-g002">Figure 2C</xref>
###xml 476 501 476 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Burkholderia pseudomallei</italic>
###xml 532 549 532 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Shigella flexneri</italic>
###xml 667 671 667 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Armougom1">[34]</xref>
###xml 872 876 872 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Notredame1">[35]</xref>
###xml 1109 1113 1107 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Poirot1">[19]</xref>
###xml 218 224 <span type="species:ncbi:13443">Coffee</span>
###xml 282 288 <span type="species:ncbi:13443">Coffee</span>
###xml 476 501 <span type="species:ncbi:28450">Burkholderia pseudomallei</span>
###xml 532 549 <span type="species:ncbi:623">Shigella flexneri</span>
###xml 559 564 <span type="species:ncbi:9606">human</span>
###xml 1164 1169 <span type="species:ncbi:9606">human</span>
Hidden Markov model (HMM) methods [33] provide an alternative and more robust approach to identify homology between distantly related proteins with low sequence similarity relative to traditional BLAST searches. The T-Coffee web server () provides a consensus sequence alignment (M-Coffee) using multiple HMM protocols [19]. A reliable alignment of conserved residues (Figure 2C) was obtained between the known T3SS structures of PrgI (PDB ID: 2JOW), BsaL (PDB ID: 2G0U) from Burkholderia pseudomallei, and MxiH (PDB ID: 2CA5) from Shigella flexneri with the human Bcl-xL (PDB ID: 1YSN) protein. The multiple-sequence alignment was obtained using EXPRESSO (3DCoffee) [34] that combines structural information with a HMM sequence alignment method. The reliability of the per residue alignment is color-coded using the CORE index (consistency of overall residue evaluation) [35], where the majority of residues were in the average to good range. The alignment of Bcl-xL with the three T3SS structures received a CORE index score of 53, where a score >/=50 indicates a 90% probability of being correctly aligned [19]. For comparison, the alignment of the three known human T3SS proteins resulted in a range of scores from 72 to 76. Thus, PrgI aligns preferentially to the other T3SS proteins, but its alignment to the pore forming helices in Bcl-xL is significant and reliable. Importantly, the sequence alignment of PrgI with Bcl-xL encompasses the same residues involved in the ligand binding sites identified by CPASS and the structural similarity identified by DaliLite.
###end p 29
###begin title 30
Identification of a Second PrgI Ligand Binding Site
###end title 30
###begin p 31
###xml 170 174 170 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Liu1">[36]</xref>
###xml 748 752 736 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Zhang1">[37]</xref>
###xml 849 858 837 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007442-g002">Figure 2B</xref>
###xml 986 990 974 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Zhang1">[37]</xref>
The identification of a compound that binds similarly to both PrgI and Bcl-xL would further establish a functional relationship between these two proteins. The BindingDB [36] was used to identify potential inhibitors of PrgI based on the CPASS predicted active site similarity with Bcl-xL. A total of 71 ligands were reported to bind Bcl-xL. A majority of the compounds were piperazine derivatives and were not readily available. Two compounds, chelerythrine and sanquinarine were identified as having affinity to Bcl-xL and were both available from commercial suppliers. Chelerythrine was selected over sanquinarine based on previous NMR screening and docking studies that suggested chelerythrine binds between alpha4, alpha5 and alpha6 of Bcl-xL [37]. This region of Bcl-xL was predicted to overlap with PrgI based on the pairwise Dali alignment (Figure 2B). Conversely, sanquinarine bound the BH3 binding cleft of Bcl-xL and thus was not selected for this secondary binding analysis [37].
###end p 31
###begin p 32
###xml 62 64 62 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 66 67 66 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 83 92 83 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007442-g003">Figure 3A</xref>
###xml 143 152 143 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007442-g003">Figure 3B</xref>
###xml 539 548 539 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007442-g003">Figure 3B</xref>
###xml 736 744 736 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007442-g004">Figure 4</xref>
A comparison between the free and chelerythrine bound PrgI 2D 15N-1H HSQC spectra (Figure 3A) identified a chelerythrine binding site on PrgI (Figure 3B). The PrgI residues that exhibited chemical shift changes upon binding chelerythrine include residues A14, K15 in helix 1 and residues Y57, N59, A60, V65, K66, V67, F68, and D72 in helix 2. The AutoDock/ADF docked structure of PrgI with chelerythrine suggests PrgI residues K15 and Y57 are the most important residues for chelerythrine binding based on a close contact with the ligand (Figure 3B). Many of the residues that show significant CSPs for PrgI bound to chelerythrine overlap with the DDAB residues, however, the chelerythrine binding site is on the opposite face of PrgI (Figure 4). This indicates that there are two ligand binding sites on PrgI that is consistent with the two known protein-protein interaction sites for PrgI self-oligomerization. The chelerythrine AutoDock docking energy decreased significantly compared to DDAB, -0.43 to -5.29 kcal/mol, respectively.
###end p 32
###begin title 33
Verification that the Bcl-xL inhibitor chelerythrine also binds PrgI.
###end title 33
###begin p 34
###xml 32 34 32 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 36 37 36 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
(A). Expanded overlay of the 2D 15N-1H HSQC spectra for free PrgI (black) and PrgI bound to chelerythrine (blue). CSPs greater than one standard deviation are boxed. (B) An AutoDock/ADF docked structure of PrgI complexed with chelerythrine based on the observed CSPs from (A). (C) The Bcl-xL region shown to bind chelerythrine is highlighted while the remaining protein structure is transparent. Chelerythrine is colored yellow and is drawn with licorice bonds. Side-chains for Y173 and V135 are shown as licorice bonds and colored grey. (D) A ribbon diagram of the AutoDock/ADF docked PrgI-chelerythrine co-structure. The PrgI-chelerythrine binding region that overlaps with Bcl-xL is highlighted. Chelerythrine is colored yellow and is drawn with licorice bonds. Side-chains for Y57 and K15 are shown as licorice bonds and colored grey. (E) An expanded view of the overlay of Bcl-xL (red) with PrgI (blue) illustrating the structural similarity of the chelerythrine binding sites.
###end p 34
###begin title 35
The two PrgI ligand binding sites identified using FAST-NMR.
###end title 35
###begin p 36
###xml 155 159 155 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Nicholls1">[79]</xref>
###xml 183 187 183 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Pettersen1">[80]</xref>
The two PrgI ligand binding sites are highlighted on an electrostatic potential surface (blue positive charge, red negative charge) calculated with DelPhi [79] implemented in Chimera [80]. The didecyldimethylammonium bromide binding site (A) is found in a region responsible for needle formation while the chelerythrine binding site (B) is found on the opposite face.
###end p 36
###begin p 37
###xml 110 126 110 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007442-g003">Figure 3C and 3D</xref>
###xml 317 326 305 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007442-g003">Figure 3C</xref>
###xml 328 332 316 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Zhang1">[37]</xref>
###xml 504 513 492 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007442-g003">Figure 3E</xref>
The binding site of chelerythrine on PrgI is nearly identical to the binding site of chelerythrine to Bcl-xL (Figure 3C and 3D). In Bcl-xL, the chelerythrine binding site is described as being located in the BH groove of helix alpha4, alpha5 and alpha6, which is composed of residues F131, R132, V135, Y173 and H177 (Figure 3C) [37]. Pairwise structure analysis between PrgI and Bcl-xL shows that Y173 of Bcl-xL and Y57 on PrgI are overlapping residues and K15 from PrgI is proximal to V135 from Bcl-xL (Figure 3E). The primary difference between the two proteins is the lack of alpha-helix 4 in PrgI, where helix 4 of Bcl-xL appears to act as a 'cap' encasing the ligand and effecting its relative binding orientation. Chelerythrine binds flat in the PrgI binding site, while the compound points into the corresponding Bcl-xL binding site partially overlaying helix alpha4. Again, both of these structures are docked models based on NMR CSPs and require a high-resolution x-ray or NMR structure to confirm the conformation of the chelerythrine binding site. It is paramount to note that this similarity in chelerythrine binding between the two proteins would have not been discovered if it was not for the identification of the initial conserved ligand binding site between PrgI and Bcl-xL using the FAST-NMR method in combination with the CPASS database.
###end p 37
###begin title 38
Discussion
###end title 38
###begin title 39
Ligand Binding Similarity of the Bcl-2 Family of Proteins with PrgI
###end title 39
###begin p 40
###xml 373 382 373 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007442-g002">Figure 2A</xref>
A structural and functional similarity between PrgI, a type three secretion system protein, and Bcl-xL, a member of the Bcl-2 family of proteins involved in eukaryotic apoptosis, was identified from a FAST-NMR ligand affinity screen in combination with a bioinformatic analysis. This association is fundamentally based on the similarity in ligand binding sites depicted in Figure 2A, where the conserved helix-turn-helix motif simply provides secondary support of a PrgI and Bcl-2 functional link. While similar active sites provide a measure of functional similarity, inferring homology based solely on the observation of a similar helix-turn-helix motif is questionable. The helix-turn-helix is a common motif and without a global sequence similarity, an evolutionary lineage based solely on active site similarity cannot be readily established. However, identifying similar ligand-binding sites between the two proteins does provide support that the proteins share a common function and are expected to bind similar ligands.
###end p 40
###begin p 41
###xml 962 970 962 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007442-g004">Figure 4</xref>
###xml 1656 1660 1656 1660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Xie1">[38]</xref>
The initial identification of the conserved DDAB ligand binding site between Bcl-xL and PrgI was used to predict, test and confirm that chelerythrine binds PrgI in a similar manner to Bcl-xL. This further supports the structural and functional similarity between PrgI and Bcl-xL, but also demonstrates the utility of active site similarity as a predictive tool for ligand binding. Chelerythrine was only tested for PrgI binding because of the proposed active site similarity with Bcl-xL. Thus, these studies have identified the first known ligands to bind PrgI (DDAB and chelerythrine). Both ligand binding sites are associated with the functionally important PrgI self-oligomerization sites. Therefore, compounds based on either the DDAB or chelerythrine scaffold may disrupt PrgI oligomerization. These compounds may serve as valuable chemical leads to develop novel antibiotics. Additionally, since the ligands bind in separate locations on the PrgI surface (Figure 4), the compounds present two distinct approaches for developing drugs targeting PrgI. Unfortunately, because chelerythrine also binds Bcl-xL it is reasonable to expect that an antibiotic designed using chelerythrine as a scaffold may produce undesirable off-target side effects. This issue may be minimized or eliminated by simply improving the PrgI binding affinity for chelerythrine derivatives. This illustrates another important feature of our FAST-NMR protocol; active site similarity is a useful tool to predict potential side effects due to off target inhibition, in addition to predicting potential drug leads. While computational methods for predicting potential drug toxicity [38] are useful because of their speed, validation requires experimental methods such as the FAST-NMR approach.
###end p 41
###begin title 42
Functional Similarity of the Bcl-2 Family of Proteins with PrgI
###end title 42
###begin p 43
###xml 132 136 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Yan1">[14]</xref>
###xml 142 149 142 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 418 422 418 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Chao1">[39]</xref>
###xml 613 617 613 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Chao1">[39]</xref>
The Bcl-2 family of proteins are essential for eukaryotic apoptosis; where Bcl-xL is responsible for repressing cell death activity [14]. The in vivo binding partners of Bcl-xL include the pro-apoptosis proteins Bax, Bak and Bid. It has been shown that expression levels of repressor (Bcl-xL) and pro-apoptosis proteins (Bax, Bak and Bid) are reciprocal in nature suggesting precise regulation of eukaryotic apoptosis [39]. A combination of mutational and structure based work has shown that the BH3 binding domain of Bcl-xL is critical for binding interactions with other Bcl-2 proteins and apoptosis regulation [39].
###end p 43
###begin p 44
###xml 193 197 193 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Chou1">[40]</xref>
###xml 198 202 198 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Suzuki1">[42]</xref>
###xml 378 382 378 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Chao1">[39]</xref>
###xml 384 388 384 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-VanderHeiden1">[43]</xref>
###xml 390 394 390 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Yan2">[44]</xref>
###xml 680 684 680 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Annis1">[45]</xref>
###xml 686 690 686 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Kuwana1">[46]</xref>
###xml 818 822 818 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Breckenridge1">[47]</xref>
###xml 972 976 948 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Fletcher1">[48]</xref>
###xml 1081 1085 1057 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Kang1">[49]</xref>
###xml 1151 1155 1127 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Billen1">[50]</xref>
The structure of Bcl-xL very closely resembles the structures of Bax, Bid, Bcl-2, and other members of the Bcl-2 family of proteins, which all resemble pore-forming domains of bacterial toxins [40]-[42]. Bcl-2, Bcl-xL, Bax and the truncated active form of Bid (tBid) have all been shown to form pores in liposomes, but a similar cellular function has only been observed for Bax [39], [43], [44]. In healthy cells, Bax is a monomer in the cytosol. Many different apoptotic signals result in the transfer of Bax to the outer mitochondrial membrane where an interaction with Bid and the lipid membrane induces Bax to form a supramolecular opening in the outer mitochondrial membrane [45], [46]. This pore structure causes the release of pro-apoptotic factors from the mitochondria into the cytoplasm to induce cell death [47] and contains approximately22 copies of Bax with a diameter of approximately20 nm. The interaction of Bcl-xL with Bax prevents Bax induced cell death [48], where drugs that disrupt Bcl-xL interacting with Bcl-2 proteins are a promising form of cancer therapy [49]. Bcl-xL has been described as a dominant-negative version of Bax [50].
###end p 44
###begin p 45
###xml 132 135 120 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Cornelis1">[9]</xref>
###xml 136 140 124 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Macnab1">[11]</xref>
###xml 304 308 292 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Galan1">[12]</xref>
###xml 309 313 297 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Yan1">[14]</xref>
###xml 606 610 594 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Kimbrough1">[10]</xref>
###xml 659 663 647 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Kuwana1">[46]</xref>
###xml 943 947 931 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Kuwana1">[46]</xref>
PrgI comprises the T3SS needle structure, which is formed by a PrgI homomultimer composed of approximately120 copies of the protein [9]-[11]. This needle structure senses and punctures host membranes forming a pore to transfer proteins to induce cell death in a mechanism similar to eukaryotic apoptosis [12]-[14]. A general conservation in function between PrgI and the Bcl-2 protein family is readily apparent; both form membrane pores via a helix-turn-helix motif through oligomerization to release effectors to stimulate cell death. Additionally, PrgI requires PrgJ for oligomerization into the needle [10] while Bax requires Bid to induce pore formation [46]. Thus, a protein interaction with other members of the Bcl-2 family is required to either promote (Bid) or inhibit (Bcl-xL) Bax oligomerization. It is also interesting that PrgI was found to bind to a lipid analog and lipids have been found to play a role in Bax oligomerization [46].
###end p 45
###begin p 46
###xml 509 513 509 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Wendt1">[51]</xref>
Importantly, the experimentally observed ligand-binding sites for both PrgI and Bcl-xL are functionally equivalent and within the conserved helix-turn-helix motif. Both sites correspond to functionally critical protein-protein interaction sites required for oligomerization and pore formation. The DDAB binding site on PrgI overlaps with key residues involved in PrgI oligomerization and needle assembly. Similarly, ABT-737 is an inhibitor of apoptosis and functions by inhibiting Bcl-xL protein interactions [51]. Thus, the similarity in the ligand-binding sites helps establish a functional link between the two proteins.
###end p 46
###begin title 47
Structural Similarity of the Bcl-2 Family of Proteins with PrgI
###end title 47
###begin p 48
###xml 66 70 66 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Chou1">[40]</xref>
###xml 72 76 72 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Muchmore1">[52]</xref>
###xml 203 212 195 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007442-g002">Figure 2A</xref>
###xml 377 386 369 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007442-g002">Figure 2B</xref>
###xml 537 546 529 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007442-g002">Figure 2C</xref>
The Bax pore-forming domain is conserved in Bcl-xL, Bcl-2 and Bid [40], [52] and corresponds to the helix-turn-helix motif (helices alpha5 and alpha6) that was identified by CPASS to be similar to PrgI (Figure 2A). Also, a comparison of the Bcl-xL and PrgI structure by DaliLite resulted in the alignment of the PrgI structure with this conserved Bcl-2 helix-turn-helix motif (Figure 2B). Additionally, a multiple sequence alignment indicated a reliable similarity between T3SS needle-forming proteins and the Bcl-2 pore-forming region (Figure 2C). Thus, the PrgI structure can be viewed as a minimalistic version of the Bcl-2 structure, and it corresponds to the functionally essential and conserved core pore-forming domain.
###end p 48
###begin p 49
###xml 159 163 159 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Jiang1">[53]</xref>
###xml 165 169 165 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Morett1">[54]</xref>
###xml 503 509 503 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 509 513 509 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Aouacheria1">[55]</xref>
Gene duplication along with insertion and/or deletions of sub-structures into variable genetic regions are known methods for the evolution of protein function [53], [54]. These processes may explain the evolution of the Bcl-2 family of proteins from a smaller PrgI-like ancestor. Since the PrgI structure overlaps with residues N136 to I182, this may suggest N- and C-terminal insertions generated a Bcl-2 protein from a PrgI-like ancestor. This is consistent with the hypothesis proposed by Aouacheria et al.[55], where the ancestral toxic pore forming domain (helices alpha5 and alpha6) required developing a means to prevent inappropriate apoptosis and to regulate cell death.
###end p 49
###begin p 50
###xml 439 443 439 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Suzuki1">[42]</xref>
###xml 445 449 445 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Cartron1">[56]</xref>
###xml 451 455 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Goping1">[57]</xref>
###xml 565 569 565 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Cartron1">[56]</xref>
###xml 571 575 571 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Goping1">[57]</xref>
###xml 789 793 785 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Suzuki1">[42]</xref>
###xml 1019 1023 1003 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Suzuki1">[42]</xref>
###xml 1025 1029 1009 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Desagher1">[58]</xref>
###xml 1139 1143 1119 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Er1">[59]</xref>
Presumably, a main function of the N- and C-terminal inserts into a PrgI-like ancestor would be to stabilize the monomer form of Bax until an apoptotic signal occurs. In effect, the insertions would provide a stronger control over the pore formation process. This is consistent with what has been experimentally observed, both the N- terminus and C-terminus residues of Bax are essential to maintain the monomer form of Bax in the cytosol [42], [56], [57]. Deletion of the first 20 amino acids from the N-terminus results in Bax being localized to the mitochondria [56], [57]. Similarly, the Bax structure indicates the C-terminal hydrophobic helix alpha9 is bent in a hydrophobic groove, but contains some critical solvent exposed polar residues that are necessary to maintain solubility [42]. In fact, a model for the translocation of Bax from the cytosol to the mitochondria requires a conformational change in Bax that opens up helix alpha9 and exposes the pore forming region composed of helices alpha5 and alpha6 [42], [58]. Deletions of 21 residues from the C-terminus, which includes part of helix alpha6, prevents oligomerization [59].
###end p 50
###begin p 51
###xml 343 347 331 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Lalier1">[60]</xref>
###xml 864 868 852 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Marlovits1">[61]</xref>
While Bax oligomerizes to form a circular pore structure containing approximately22 copies, this oligomerization process does not extend to form layers like the PrgI needle structure. The conformational change in Bax results in the globular domain remaining in the cytosol and sterically prevents oligomerization perpendicular to the membrane [60]. Thus, the structural insert that maintains a monomer Bax in the cytosol also prevents an unnecessary linear extension of the Bax oligomer out of the mitochondria membrane. Conversely, regulating PrgI oligomerization is not necessary since the assembly of the T3SS system is not detrimental to the cell. Therefore, a minimal pore-forming structure is all that is necessary for the T3SS system. The length of the PrgI needle is controlled by the proper assembly of the inner rod (PrgJ) that requires the InvJ protein [61]. The deletion of InvJ results in long non-functional needles.
###end p 51
###begin title 52
An Evolutionary Relationship between T3SS and Eukaryotic Apoptosis?
###end title 52
###begin p 53
###xml 484 488 476 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Aouacheria1">[55]</xref>
###xml 554 558 546 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Liu2">[62]</xref>
###xml 604 608 596 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Gophna1">[63]</xref>
###xml 668 672 660 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Rosinski1">[64]</xref>
###xml 1052 1056 1044 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Rosinski1">[64]</xref>
###xml 1419 1423 1411 1415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Kannan1">[65]</xref>
###xml 1531 1535 1523 1527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Shapiro1">[66]</xref>
Based on the observed similarity in the structure and function between PrgI and the Bcl-2 protein family it is tempting to hypothesize that the proteins share a common ancestor. The structural comparison of PrgI with the Bcl-2 family of proteins discussed above suggests a possible evolutionary path. A common ancestral protein has been suggested for the Bcl-2 protein family, where pore formation using helices alpha5 and alpha6 is the ancestral protein's predicted primary function [55]. Similarly, T3SS are also predicted to evolve from a single gene [62] that is a simple but versatile export system [63]. Again, the helix-turn-helix is a common and ancient motif [64] demonstrating both its diverse utility and evolutionary stability. Thus, it is plausible that a simple and ancient PrgI-like protein could be an evolutionary precursor to both the Bcl-2 protein family and PrgI. It also appears unlikely that PrgI and the Bcl-2 protein family would evolve through a convergent process since the helix-turn-helix is such a simple and ancient motif [64] and essential to the function of both proteins. Evolving a readily available helix-turn-helix protein into either PrgI or the Bcl-2 protein family seems like a simpler path than the conversion of a uniquely distinct fold to incorporate a core helix-turn-helix motif. Also, the evolution of proteins from simple structural components has been previously proposed [65] and is consistent with other general evolutionary trends where complex systems evolve from simpler systems [66].
###end p 53
###begin p 54
###xml 306 310 306 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-McCann1">[67]</xref>
###xml 312 316 312 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Gophna2">[68]</xref>
###xml 558 562 558 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Gray1">[69]</xref>
###xml 564 568 564 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Koonin1">[70]</xref>
###xml 591 595 587 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Gray1">[69]</xref>
###xml 670 674 666 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Gophna1">[63]</xref>
###xml 676 680 672 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Gauthier1">[71]</xref>
###xml 682 686 678 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Batut1">[72]</xref>
###xml 893 897 889 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-PallenMark1">[73]</xref>
###xml 899 903 895 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Mulkidjanian1">[74]</xref>
###xml 1062 1066 1058 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Koonin2">[75]</xref>
By analogy, the sharing of a common ancestor by PrgI and the Bcl-2 family of proteins would imply an evolutionary relationship between the T3SS and eukaryotic apoptosis systems. T3SS is a prime example of a vestigial system and an important illustration of the stepwise evolution of the flagella machinery [67], [68]. Therefore, it is reasonable to expect that other systems will be identified that share an evolutionary relationship with T3SS. T3SS is also an ancient system and clearly predates the origin of the mitochondria from prokaryote endosymbiosis [69], [70]. alpha-proteobacteria [69], which are close relatives of the mitochondria, are known to contain T3SS [63], [71], [72]. Could an obsolete T3SS system contribute valuable components to the eukaryotic apoptosis system after endosymbiosis? An evolutionary link has already been observed between a mitochondrial and T3SS protein [73], [74]. Furthermore, a detailed analysis of the origin of apoptotic proteins suggests a pivotal role for bacterial proteins in the evolution of eukaryotic apoptosis [75].
###end p 54
###begin title 55
Materials and Methods
###end title 55
###begin title 56
FAST-NMR Screen of PrgI
###end title 56
###begin p 57
###xml 4 26 4 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Salmonella typhimurium</italic>
###xml 107 111 107 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Mercier3">[23]</xref>
###xml 137 140 137 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Powers1">[5]</xref>
###xml 142 145 142 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Mercier1">[6]</xref>
###xml 161 163 161 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 283 285 283 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 287 288 287 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 431 434 431 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Mercier1">[6]</xref>
###xml 454 455 454 455 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 662 666 662 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Shortridge1">[25]</xref>
###xml 681 683 681 683 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 685 686 685 686 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 862 864 862 864 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 866 867 866 867 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 1039 1046 1039 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;NH</italic>
###xml 1088 1089 1084 1085 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 1123 1131 1119 1123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;15N</italic>
###xml 1173 1175 1165 1167 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 4 26 <span type="species:ncbi:90371">Salmonella typhimurium</span>
The Salmonella typhimurium type three secretion protein (T3SS) PrgI was screened with a functional library [23] using our FAST-NMR assay [5], [6]. Unlabeled and 15N labeled monomeric PrgI was graciously provided by Dr. Roberto DeGuzman (University of Kansas) along with the assigned 15N-1H HSQC spectrum. Sample preparation and experimental parameters for the NMR screening were executed in the same manner as described previously [6]. A total of 113 1D 1H NMR line-broadening spectra were collected to identify 5 binders from the functional chemical library of 437 compounds. Measurement of binding dissociation constants were completed as described previously [25]. Secondary 2D 15N-1H HSQC NMR experiments were collected only for the 5 compounds identified as binders in the line-broadening experiments. Chemical shift perturbations (CSPs) (eq 1) from the 2D 15N-1H HSQC NMR experiments were used to identify the PrgI ligand binding site, where only residues with a CSP greater than one standard deviation from the mean were used:where DeltaNH is the difference between free and bound 1H amide chemical shifts (ppm) and Delta15N is the difference between free and bound 15N chemical shifts (ppm).
###end p 57
###begin p 58
###xml 150 154 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Stark1">[24]</xref>
###xml 412 416 412 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Morris1">[27]</xref>
###xml 596 599 596 599 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CSP</sub>
###xml 595 599 595 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>CSP</sub></italic>
###xml 689 690 689 690 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 688 690 688 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>S</sub></italic>
###xml 961 965 959 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Stark1">[24]</xref>
Our rapid approach to determine a ligand binding orientation was employed to determine a PrgI co-structure in the same manner as described previously [24]. The CSPs minimize the search space by using a significantly reduced AutoDock 3D grid. AutoDock 4.0 was used to generate 100 docked PrgI-ligand co-structures using the Lamarckian search algorithm with a population size of 300 and 500,000 energy evaluations [27]. Our AutoDockFilter (ADF) program then uses an NMR energy function based on the magnitude of CSPs to select the best ligand conformation. where ADF calculates a pseudo-distance (dCSP) based on the magnitude of the NH CSP, which is then compared to the shortest distance (dS) between any atom in the residue that incurred an NH CSP and any atom in each docked ligand conformer. Comparison of these CSP-directed and selected ligand-docked structures with experimental x-ray and NMR structures has yielded an overall average rmsd of 1.17+/-0.74 A [24].
###end p 58
###begin p 59
###xml 191 195 191 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Henikoff1">[76]</xref>
###xml 197 201 197 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Henikoff2">[77]</xref>
###xml 221 223 221 223 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ab</sub>
###xml 220 223 220 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S<sub>ab</sub></italic>
###xml 220 223 220 223 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>S<sub>ab</sub></italic></bold>
###xml 244 245 244 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 244 245 244 245 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>a</italic></bold>
###xml 255 256 255 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 255 256 255 256 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>n</italic></bold>
###xml 297 298 297 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 297 298 297 298 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>b</italic></bold>
###xml 338 339 338 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 338 339 338 339 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>m</italic></bold>
###xml 351 354 351 354 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i,j</sub>
###xml 350 354 350 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p<sub>i,j</sub></italic>
###xml 350 354 350 354 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>p<sub>i,j</sub></italic></bold>
###xml 422 423 422 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</italic>
###xml 422 423 422 423 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>i</italic></bold>
###xml 441 442 441 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 441 442 441 442 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>a</italic></bold>
###xml 456 457 456 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">j</italic>
###xml 456 457 456 457 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>j</italic></bold>
###xml 475 476 475 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 475 476 475 476 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>b</italic></bold>
###xml 483 486 479 482 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i,j</sub>
###xml 478 486 478 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;<sub>i,j</sub></italic>
###xml 478 486 478 482 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>&#916;<sub>i,j</sub></italic></bold>
###xml 582 583 574 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</italic>
###xml 582 583 574 575 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>i</italic></bold>
###xml 588 589 580 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">j</italic>
###xml 588 589 580 581 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>j</italic></bold>
###xml 596 599 588 591 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">min</sub>
###xml 601 602 593 594 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 595 602 587 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>min</sub>/d<sub>i</sub></italic>
###xml 595 602 587 594 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>d<sub>min</sub>/d<sub>i</sub></italic></bold>
###xml 767 769 759 761 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ab</sub>
###xml 766 769 758 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S<sub>ab</sub></italic>
###xml 766 769 758 761 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>S<sub>ab</sub></italic></bold>
###xml 824 825 816 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</italic>
###xml 824 825 816 817 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>i</italic></bold>
###xml 843 844 835 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 843 844 835 836 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>a</italic></bold>
###xml 858 859 850 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">j</italic>
###xml 858 859 850 851 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>j</italic></bold>
###xml 877 878 869 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 877 878 869 870 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>b</italic></bold>
###xml 931 932 923 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</italic>
###xml 931 932 923 924 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>i</italic></bold>
###xml 937 938 929 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">j</italic>
###xml 937 938 929 930 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>j</italic></bold>
###xml 1005 1006 997 998 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 1005 1006 997 998 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>a</italic></bold>
###xml 1011 1012 1003 1004 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 1011 1012 1003 1004 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>b</italic></bold>
###xml 1162 1163 1146 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 1162 1163 1146 1147 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>a</italic></bold>
###xml 1226 1228 1210 1212 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ab</sub>
###xml 1225 1228 1209 1212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S<sub>ab</sub></italic>
###xml 1225 1228 1209 1212 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>S<sub>ab</sub></italic></bold>
###xml 1319 1320 1303 1304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 1319 1320 1303 1304 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>a</italic></bold>
A co-structure of the lipid derivative DDAB bound to PrgI was uploaded to the CPASS database () to identify proteins with similar ligand binding sites by maximizing an rmsd weighted BLOSUM62 [76], [77] scoring function (Sab). where active site a contains n residues and is compared to active site b from the CPASS database which contains m residues, pi,j is the BLOSUM62 probability for amino-acid replacement for residue i from active site a with residue j from active site b, Deltai,j is a corrected root-mean square difference in the Calpha coordinate positions between residues i and j, and dmin/di is the ratio of the shortest distance to the ligand among all amino-acids in the active site compared to the current amino-acid's shortest distance to the ligand. Sab is only summed over the optimal alignment for residue i from active site a with residue j from active site b. It is not summed over all possible combinations of i and j. If the number of residues are not identical between active sites a and b (nnot equalm), then the additional residues will not have a corresponding match. Each residue can only be used once in the alignment. If active site a contains unmatched residues, then no contribution is made to Sab which effectively reduces the maximal possible score that can be achieved for active site a. Currently, there are approximately35,000 protein-ligand structures in the CPASS database. CPASS runs on a 16 node Beowulf Linux cluster, requires approximately 40 sec for each pair-wise comparison and takes approximately24 hrs to complete a full search against the entire database.
###end p 59
###begin title 60
Structure Similarity Searching
###end title 60
###begin p 61
###xml 50 54 50 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Wang1">[15]</xref>
###xml 81 85 81 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Oltersdorf1">[28]</xref>
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Holm1">[29]</xref>
###xml 350 354 350 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Dietmann1">[18]</xref>
Native protein structures for PrgI (PDB ID: 2JOW) [15] and Bcl-xL (PDB ID: 1YSN) [28] were uploaded to the DaliLite [29] web server () to identify regions of structure homology between the two proteins. To identify structure similarity and possible homologies between other proteins within the PDB, the structures were also uploaded to the full Dali [18] web server (). A truncated version of the Bcl-xL structure was generated by identifying the amino acids within regions of structure similarity and removing these residues from the native PDB file. The truncated PDB file was searched for regions of similarity using the DaliLite web server ().
###end p 61
###begin title 62
###xml 48 54 <span type="species:ncbi:13443">Coffee</span>
Sequence Similarity Searching using BLAST and T-Coffee
###end title 62
###begin p 63
###xml 167 181 167 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. typhimurium</italic>
###xml 270 282 270 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Homo sapiens</italic>
###xml 393 397 393 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Altschul1">[30]</xref>
###xml 523 537 523 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. typhimurium</italic>
###xml 559 574 559 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pseudomallei</italic>
###xml 599 610 599 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. flexneri</italic>
###xml 683 687 683 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Poirot1">[19]</xref>
###xml 780 784 780 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Armougom1">[34]</xref>
###xml 167 181 <span type="species:ncbi:90371">S. typhimurium</span>
###xml 270 282 <span type="species:ncbi:9606">Homo sapiens</span>
###xml 523 537 <span type="species:ncbi:90371">S. typhimurium</span>
###xml 559 574 <span type="species:ncbi:28450">B. pseudomallei</span>
###xml 599 610 <span type="species:ncbi:623">S. flexneri</span>
###xml 676 682 <span type="species:ncbi:13443">Coffee</span>
Sequences from the T3SS and apoptosis regulation were downloaded from the NCBI server () and included PrgI (gi|16766179), InvJ (gi|16766198) and InvG (gi|474941) from S. typhimurium, and Bcl-xL, (gi|510901), Bak1 (gi|82571458), Bid (gi|4557361) and Bax (gi|231632) from Homo sapiens respectively. A full BLAST search was completed using these sequences associated with both systems as queries [30]. All BLAST sequence searches used default web settings. In addition, the sequences and structures for Bcl-xL (PDB-ID: 1YSN), S. typhimurium PrgI (PDB-ID: 2JOW), B. pseudomallei BsaL (PDB-ID: 2GOU) and S. flexneri MxiH (PDB-ID: 2CA5) obtained from the PDB were uploaded to the T-Coffee [19] web server () to obtain a multiple sequence alignment using the EXPRESSO(3DCoffee) software [34]. Only the sequence region of the Bcl-xL structure that contained the pore-forming domain and yielded the highest alignment score was used for the multiple sequence alignment.
###end p 63
###begin title 64
Secondary Binding Site Similarity between Bcl-xL and PrgI
###end title 64
###begin p 65
###xml 97 101 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Liu1">[36]</xref>
###xml 193 195 193 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 197 198 197 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 245 247 241 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 456 458 448 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 460 461 452 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 592 596 584 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Stark1">[24]</xref>
###xml 648 652 640 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007442-Zhang1">[37]</xref>
To further support a structural and functional similarity between Bcl-xL and PrgI, the BindingDB [36] () was searched for commercially available compounds to test for binding to PrgI. The free 15N-1H HSQC spectrum was collected using 100 microM 15N labeled PrgI in 20 mM bis-Tris buffer with 100 mM sodium chloride at pH 7.0. A second PrgI sample was prepared in the same manner as above with the addition of 500 microM chelerythrine to generate the bound 15N-1H HSQC spectrum. Chemical shift perturbations and a PrgI-chelerythrine docked co-structure were determined as described previously [24] and was compared to the Bcl-xL-chelerythrine model [37].
###end p 65
###begin p 66
###xml 126 128 126 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 130 131 130 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
We would like to thank Dr. Roberto De Guzman from the University of Kansas for supplying the PrgI samples and the assigned 2D 15N-1H HSQC spectrum. We would also like to thank Dr. Henry Mok from the National University of Singapore for providing us with the coordinates for the Bcl-xL-chelerythrine model.
###end p 66
###begin title 67
References
###end title 67
###begin article-title 68
Divergent evolution of enzymatic function: mechanistically diverse superfamilies and functionally distinct suprafamilies.
###end article-title 68
###begin article-title 69
Universally conserved positions in protein folds: reading evolutionary signals about stability, folding kinetics and function.
###end article-title 69
###begin article-title 70
Binding similarity network of ligand.
###end article-title 70
###begin article-title 71
Ligand binding: functional site location, similarity and docking.
###end article-title 71
###begin article-title 72
The application of FAST-NMR for the identification of novel drug discovery targets.
###end article-title 72
###begin article-title 73
FAST-NMR: functional annotation screening technology using NMR spectroscopy.
###end article-title 73
###begin article-title 74
Functional genomics and NMR spectroscopy.
###end article-title 74
###begin article-title 75
Comparison of protein active site structures for functional annotation of proteins and drug design.
###end article-title 75
###begin article-title 76
Assembly and function of type III secretory systems.
###end article-title 76
###begin article-title 77
###xml 53 75 <span type="species:ncbi:90371">Salmonella typhimurium</span>
Assembly of the type III secretion needle complex of Salmonella typhimurium.
###end article-title 77
###begin article-title 78
How bacteria assemble flagella.
###end article-title 78
###begin article-title 79
Salmonella interactions with host cells: type III secretion at work.
###end article-title 79
###begin article-title 80
Molecular mechanisms of bacteria induced apoptosis.
###end article-title 80
###begin article-title 81
Mechanisms of apoptosis through structural biology.
###end article-title 81
###begin article-title 82
Differences in the electrostatic surfaces of the type III secretion needle proteins PrgI, BsaL, and MxiH.
###end article-title 82
###begin article-title 83
Molecular model of a type III secretion system needle: Implications for host-cell sensing.
###end article-title 83
###begin article-title 84
###xml 4 19 <span type="species:ncbi:632">Yersinia pestis</span>
The Yersinia pestis type III secretion needle plays a role in the regulation of Yop secretion.
###end article-title 84
###begin article-title 85
A fully automatic evolutionary classification of protein folds: Dali Domain Dictionary version 3.
###end article-title 85
###begin article-title 86
Tcoffee@igs: A web server for computing, evaluating and combining multiple sequence alignments.
###end article-title 86
###begin article-title 87
Identification of chelerythrine as an inhibitor of BclXL function.
###end article-title 87
###begin article-title 88
The Type III secretion system of Gram-negative bacteria: a potential therapeutic target?
###end article-title 88
###begin article-title 89
A multi-step NMR screen for the identification and evaluation of chemical leads for drug discovery.
###end article-title 89
###begin article-title 90
Design and characterization of a functional library for NMR screening against novel protein targets.
###end article-title 90
###begin article-title 91
Rapid protein-ligand costructures using chemical shift perturbations.
###end article-title 91
###begin article-title 92
Estimating protein-ligand binding affinity using high-throughput screening by NMR.
###end article-title 92
###begin article-title 93
###xml 69 91 <span type="species:ncbi:90371">Salmonella typhimurium</span>
Molecular characterization and assembly of the needle complex of the Salmonella typhimurium type III protein secretion system.
###end article-title 93
###begin article-title 94
Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function.
###end article-title 94
###begin article-title 95
An inhibitor of Bcl-2 family proteins induces regression of solid tumours.
###end article-title 95
###begin article-title 96
DaliLite workbench for protein structure comparison.
###end article-title 96
###begin article-title 97
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.
###end article-title 97
###begin article-title 98
Clustal W and Clustal X version 2.0.
###end article-title 98
###begin article-title 99
Twilight zone of protein sequence alignments.
###end article-title 99
###begin article-title 100
Hidden Markov Models for prediction of protein features.
###end article-title 100
###begin article-title 101
###xml 101 107 <span type="species:ncbi:13443">Coffee</span>
Expresso: automatic incorporation of structural information in multiple sequence alignments using 3D-Coffee.
###end article-title 101
###begin article-title 102
Using multiple alignment methods to assess the quality of genomic data analysis.
###end article-title 102
###begin article-title 103
BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities.
###end article-title 103
###begin article-title 104
Chelerythrine and sanguinarine dock at distinct sites on BclXL that are not the classic BH3 binding cleft.
###end article-title 104
###begin article-title 105
Drug discovery using chemical systems biology: identification of the protein-ligand binding network to explain the side effects of CETP inhibitors.
###end article-title 105
###begin article-title 106
BCL-2 family: regulators of cell death.
###end article-title 106
###begin article-title 107
Solution structure of BID, an intracellular amplifier of apoptotic signaling.
###end article-title 107
###begin article-title 108
Solution structure of the proapoptotic molecule BID: a structural basis for apoptotic agonists and antagonists.
###end article-title 108
###begin article-title 109
Structure of Bax: coregulation of dimer formation and intracellular localization.
###end article-title 109
###begin article-title 110
Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis?
###end article-title 110
###begin article-title 111
tBid forms a pore in the liposome membrane.
###end article-title 111
###begin article-title 112
Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis.
###end article-title 112
###begin article-title 113
Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane.
###end article-title 113
###begin article-title 114
Regulation of mitochondrial membrane permeabilization by BCL-2 family proteins and caspases.
###end article-title 114
###begin article-title 115
Apoptosis is triggered when prosurvival Bcl-2 proteins cannot restrain Bax.
###end article-title 115
###begin article-title 116
Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy.
###end article-title 116
###begin article-title 117
Bcl-XL inhibits membrane permeabilization by competing with Bax.
###end article-title 117
###begin article-title 118
Discovery of ABT-263, a Bcl-family protein inhibitor: observations on targeting a large protein-protein interaction.
###end article-title 118
###begin article-title 119
###xml 27 32 <span type="species:ncbi:9606">human</span>
X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death.
###end article-title 119
###begin article-title 120
Insertions and the emergence of novel protein structure: a structure-based phylogenetic study of insertions.
###end article-title 120
###begin article-title 121
Evolution of new protein function: recombinational enhancer Fis originated by horizontal gene transfer from the transcriptional regulator NtrC.
###end article-title 121
###begin article-title 122
Phylogenomics of life-or-death switches in multicellular animals: Bcl-2, BH3-Only, and BNip families of apoptotic regulators.
###end article-title 122
###begin article-title 123
###xml 143 151 <span type="species:ncbi:9606">patients</span>
The expression of a new variant of the pro-apoptotic molecule Bax, Baxpsi, is correlated with an increased survival of glioblastoma multiforme patients.
###end article-title 123
###begin article-title 124
Regulated targeting of BAX to mitochondria.
###end article-title 124
###begin article-title 125
Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis.
###end article-title 125
###begin article-title 126
Control of Bax homodimerization by its carboxyl terminus.
###end article-title 126
###begin article-title 127
Bax activation and mitochondrial insertion during apoptosis.
###end article-title 127
###begin article-title 128
Assembly of the inner rod determines needle length in the type III secretion injectisome.
###end article-title 128
###begin article-title 129
Stepwise formation of the bacterial flagellar system.
###end article-title 129
###begin article-title 130
Bacterial type III secretion systems are ancient and evolved by multiple horizontal-transfer events.
###end article-title 130
###begin article-title 131
Molecular evolution of helix-turn-helix proteins.
###end article-title 131
###begin article-title 132
Did Protein Kinase Regulatory Mechanisms Evolve Through Elaboration of a Simple Structural Component?
###end article-title 132
###begin article-title 133
Small molecule interactions were central to the origin of life.
###end article-title 133
###begin article-title 134
Evolution of the type III secretion system and its effectors in plant-microbe interactions.
###end article-title 134
###begin article-title 135
Bacterial type III secretion systems are ancient and evolved by multiple horizontal-transfer events.
###end article-title 135
###begin article-title 136
The origin and early evolution of mitochondria.
###end article-title 136
###begin article-title 137
Origin and evolution of eukaryotic apoptosis: the bacterial connection.
###end article-title 137
###begin article-title 138
Bacterial Injection Machines.
###end article-title 138
###begin article-title 139
The evolution of chronic infection strategies in the a-proteobacteria.
###end article-title 139
###begin article-title 140
Evolutionary links between FliH/YscL-like proteins from bacterial type III secretion systems and second-stalk components of the FoF1 and vacuolar ATPases.
###end article-title 140
###begin article-title 141
Inventing the dynamo machine: the evolution of the F-type and V-type ATPases.
###end article-title 141
###begin article-title 142
Origin and evolution of eukaryotic apoptosis: the bacterial connection.
###end article-title 142
###begin article-title 143
Amino acid substitution matrices from protein blocks.
###end article-title 143
###begin article-title 144
Performance evaluation of amino acid substitution matrices.
###end article-title 144
###begin article-title 145
VMD: visual molecular dynamics.
###end article-title 145
###begin article-title 146
A rapid finite difference algorithm, utilizing successive over-relaxation to solve the Poisson-Boltzmann equation.
###end article-title 146
###begin article-title 147
UCSF Chimera-a visualization system for exploratory research and analysis.
###end article-title 147
###begin p 148
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 148
###begin p 149
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
###xml 62 69 <span type="species:ncbi:4097">Tobacco</span>
Funding: This work was supported by a grant from the Nebraska Tobacco Settlement Biomedical Research Development Funds and, in part, by award number R21AI081154 from the National Institute of Allergy and Infectious Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases. Research was performed in facilities renovated with support from the NIH under grant RR015468-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 149

